Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist widely studied for its effects on glucose metabolism, appetite regulation, and weight management. Each vial is third-party tested for purity verification.



Research applications include metabolic syndrome studies, glucose homeostasis research, and appetite pathway investigation.